Explore key data across pivotal studies.
The most clinically validated tissue-free test for ctDNA monitoring.*
Home Screening MRD + Monitoring Treatment Selection
ctDNA, circulating tumor DNA.
*When compared to other tissue-free testing companies. Comparisons are based on publicly available information as of October 2025.
Important note: Guardant Reveal was developed as a Laboratory Developed Test (LDT), and its performance characteristics determined, by the Guardant Health Clinical Laboratory in Redwood City, CA, USA, which is certified under the Clinical Laboratory
Improvement Amendments of 1988 (CLIA) as qualified to perform high-complexity clinical testing. This test has not been cleared or approved by the US FDA.